NCI/CDISC or User Specified CT
|
|
- Ashlynn Eleanore Austin
- 6 years ago
- Views:
Transcription
1 NCI/CDISC or User Specified CT Q: When to specify CT? CT should be provided for every variable with a finite set of valid values (e.g., the variable AESEV in ADAE can have the values MILD, MODERATE or SEVERE). Even if a variable has one valid value, it may be an advantage to specify a codelist for validation purposes. Multiple variables can reference the same codelist (e.g. the NY codelist is used for ITTFL, PPROTFL, SAFFL, etc.). The column "Controlled Terms, Codelist or Format" in the SDTM IG and the column "Codelist / Controlled Terms" in the ADaM IG are generally a good reference when deciding on the need for a CT for a specific variable. Note that ISO 8601 is a presentation format rather than CT, therefore no CT reference is specified when compiling the metadata for a ISO 8601 formatted datetime or duration. The stylesheet provided with the Define-XML v2.0 package automatically populates the Controlled Terms/Codelist column with "ISO 8601" where applicable. Also note that SAS specific formats (e.g., date9. for ADaM numeric date variables) are considered as Display Formats rather than CT. This type of metadata will be shown in the Length/Display Format column by the stylesheet mentioned above. Variable Label Key Type Length / Display Format Controlled Terms or Format Race Race text 20 < Race> Source/Derivation/ Comment Predecessor: DM.RACE VISIT1DT Date of Visit 1 integer date9. Derived: SV.SVSTDTC when SV. VISITNUM=1, converted to SAS date RFSTDTC Subject Reference Start Date/Time date ISO8601 Predecessor: DM. RFSTDTC For many variables (e.g., SEX, RACE, AESEV) the valid values are defined in the NCI/CDISC Terminology files. For other variables (e.g., SEXN, PARAMCD, PARAM) it is up to the producer to define the valid values of those variables. Q: What if valid values differ based on different values of another variable? Different sets of valid values may be applicable for a given variable in a vertically structured dataset (e.g., ADaM BDS datasets) when looking at different subsets of records defined by where clauses (see example below). Example USUBJID PARAMCD PARAM AVAL AVALC 1 CGI0101 CGI01-Severity of Illness 1 Normal, not at all ill 1 CGI0102 CGI01-Global Improvement 1 Very much improved Codelist (CGI0101N) for AVAL WHERE PARAMCD="CGI0101": 0=Not assessed 1=Normal, not at all ill
2 2=Borderline mentally ill 3=Mildly ill 4=Moderately ill 5=Markedly ill 6=Severely ill 7=Among the most extremely ill patients Codelist (CGI0102N) for AVAL WHERE PARAMCD="CGI0102": 0=Not assessed 1=Very much improved 2=Much improved 3=Minimally improved 4=No change 5=Minimally worse 6=Much worse 7=Very much worse Note that the decodes in this example also form the valid list of values for AVALC for the given where conditions. Value-level metadata can be used to show which codelist is associated with AVAL/AVALC based on the values of PARAMCD as shown in the table below. Parameter Value List - ADQSCGI [AVAL] Variable Where Type Length / Display Format Controlled Terms or Format Source/Derivation/Comment AVAL AVAL PARAMCD = CGI0101" (CGI01-Severity of Illness) PARAMCD = "CGI0102" (CGI01-Global Improvement) integer 8 CGI0101N Derived: QS.QSSTRESN where integer 8 CGI0102N Derived: QS.QSSTRESN where Parameter Value List - ADQSCGI [AVALC] Variable Where Type Length / Display Format Controlled Terms or Format Source/Derivation/Comment AVALC AVALC PARAMCD = CGI0101" (CGI01-Severity of Illness) PARAMCD = "CGI0102" (CGI01-Global Improvement) text 40 CGI0101 Derived: QS.QSORRES where text 40 CGI0102 Derived: QS.QSORRES where Q: What to specify, the full list of applicable values for the specific study or only the values that actually occurred? All values in the permissible value set for the study should be included, whether they are represented in the submitted data or not (see SDTM IG 3.1.2, Section CONTROLLED TERMINOLOGY VALUES). For example, if there was the possibility to classify severity as MILD, MODERATE or SEVERE, but only events of mild severity were reported, the full list of possible values, i.e. MILD, MODERATE, SEVERE would be included on the define.xml file. The same rule applies to ADaM.
3 Q: Do we include missing values in CT? Note that a null value should not be included in the permissible value set. A null value is implied for any list of controlled terms unless the variable is Required (see SDTM IG 3.1.2, Section CONTROLLED TERMINOLOGY VALUES). Consequently null values should also not be included in the CT for ADaM. Q: When to use Enumerated Items vs. when to use Codelists? Define-XML provides the possibility of two types of CT definitions: Enumerated Item Lists include a simple list of valid values. Code Lists provide a decode for each valid value. Use the enumerated item lists, if the set of values itself is sufficient for data interpretation (e.g. CT for RACE). Use Codelists, if decodes for the valid values facilitate data interpretation (e.g. CTs for ARMCD, VISITNUM, PARAMCD, ADaM numeric variables with suffix N like SEXN or RACEN for their primary character counterparts). Age Group [CL.AGEGR1] < >80 Age Group (N) [CL.AGEGR1N] 1 < >80 Q: How to deal with related CTs (e.g., VISIT-VISITNUM, AVISITN-AVISIT, ARMCD-ARM, PARAMCD-PARAM)? Variables that have related CT, such as AVISIT & AVISITN or PARAMCD & PARAM, should have separate CT for each related variable and should populate DECODE with the valid value of the related variable. For example, in the table below, the value of DECODE for PARAMCD and PARAMN matches the submission value for PARAM. CTLIST CTLIST DESCRIPTION XMLTYPE SUBMISSION VALUE DECODE CT Type ADVSPARAMCD Vitals Parameter Code text HEIGHTCM Height (cm) Codelist ADVSPARAMN Vitals Parameter (N) integer 1 Height (cm) Codelist ADVSPARAM Vitals Parameter text Height (cm) Enumerated Item List There is no rule, which precludes the use of codelists (permitted values + display values) for CT with self-explanatory values. For documentation purposes, it is sufficient to list the valid values for variables like AESEV. The display value does not need to be provided.
4 Severity/Intensity Scale for Adverse Events [CL.AESEV, C66769] MILD [ C41338] MODERATE [ C41339] SEVERE [ C41340] When needed for other operational purposes, e.g., to facilitate display generation when style guides recommends different casing (e.g., mixed case instead of upper case), the valid values could also be provided in a codelist. Severity/Intensity Scale for Adverse Events [CL.AESEV, C66769] MILD [ C41338] MODERATE [ C41339] SEVERE [ C41340] Mild Moderate Severe Correspondingly, there is no requirement that decodes in the codelist for the ADaM numeric code variable values (e.g. AESEVN) must match the spelling/casing of the respective character variable values (e.g., AESEV). AESEVN [CL.AESEVN] 1 Mild 2 Moderate 3 Severe Q: Are there any CT naming conventions? For NCI/CDISC CT, the CodeList Name attribute must exactly match the CodeList Name from the published Controlled Terminology ODM (see Define-XML v2.0, Section ). These codelist names should not be used for sponsor specific CT. Examples for NCI/CDISC CT Codelist Reference in SDTM or ADaM Implementation Guide CodeList Name NY OUT AGEU DTYPE No Yes Response Outcome of Event Age Unit Derivation Type Q: Extended CT? If a NCI/CDISC CT is defined as extensible by CDISC, sponsor specific additional values can be added. Before defining an additional value, it should be checked whether the suggested value is not just a synonym for an available CT value. If this is not the case, the sponsor specific value can be added but must be marked as an extended value in define.xml.
5 Q: How to deal with different subsets of CT? Some variables in SDTM or ADaM datasets share a common NCI/CDISC CT reference (e.g., the standard "No Yes Response" (NY) CT is referenced for the SDTM IESTRESC, --BLFL, etc. and also for the ADaM variables ABLFL, ITTFL, ITTRFL, etc.). However, only a subset of the values defined in the respective NCI/CDISC CT may be applicable for a specific variable (e.g., values N and Y are applicable for ITTFL whereas only Y is applicable for --BLFL or ABLFL). From a user's perspective, it is useful to know which specific set of values are applicable for a certain variable. The information is also useful for validation. That means, different codelist subsets are needed for different sets of valid values for different variables. However, this contradicts the codelist naming business rule that requires the exact Codelist Name as specified in the published NCI/CDISC Controlled Terminology ODM. Therefore the following convention is suggested: Assign unique names for each required subset of a CT. If the CT is defined by NCI/CDISC, the following naming convention is sugested: <Codelist name as published in the NCI/CDISC ODM>< unique subset identifier suffix>. The subset identifier suffix is used to make a distinction between different subsets of CT applicable for different variables. Example showing two subsets of the CDISC No Yes Response CT CodeList CodeList Name CodeList Coded Value CodeList Decode CL.NY No Yes Response N No CL.NY No Yes Response Y Yes CL.NY_Y No Yes Response (Subset for 'Y') Y Yes When the define.xml includes both the full CDISC CT definition as defined in the NCI EVS source and one or more CT subsets, a subset identifier is added to the CodeList Name for each included CT subset. When the only reference to a CT in a define.xml file is to a subset the code list name does not need to include the suffix. Q: Where to specify which NCI/CDISC CT version was used for the trial? Define-XML v2.0 does not include a specific element or attribute for the NCI/CDISC CT version used in the given study. The NCI/CDISC CT version should therefore be included in the study data reviewer's guide for SDTM and in the analysis data reviewer's guide for ADaM. External CT Q: Which External Codelists are commonly included in define.xml files for submissions? References to the MedDRA dictionary for coding of adverse event and medical history and references to the WHO Drug dictionary for coding of concomitant medication are commonly used. Q: Are there any naming conventions for external codelists? There are no naming conventions for external codelist references. Q: Is there any choice when to refer to an external codelist and when to specify a trial specific one?
6 In the SDTM define.xml example published with the Define-XML v2.0 package the external codelist ISO3166 is referenced for the SDTM variable COUNTRY in the domain DM. Variable Label Key Type Length Controlled Terms or Format Origin Derivation/Comment COUNTRY Country text 3 ISO3166 Assigned External Dictionaries Reference Name External Dictionary Dictionary Version ISO3166 (CL.ISO3166) ISO3166 An alternative option to handle this, particularily for trials that are only conducted in a small number of countries, would be to specify a Codelist reference with name Country (NCI C-Code: C66786) and to provide the individual country values applicable for the trial in a Codelist. This would allow the reviewer to see the countries in which the trial was conducted. Variable Label Key Type Length Controlled Terms or Format COUNTRY Country text 3 [ DEU = Germany, USA = United States ] < Country> Origin Assigned Derivation/Comment Country [CL.COUNTRY, C66786] DEU [ C16636] USA [ C17234] Germany Unites States Q: For which variables do we generally specify an external codelist reference? All variables that are derived from different hierarchy levels of external dictionaries should reference the respective dictionary. Since we need to specify a data type for every external dictionary, we may need to create two different dictionary references to the same dictionary version, i.e. one for the character variables and one for the numeric variables. Variable Label Type Controlled Terms or Format AELLT Lowest Level Term text Adverse Event Dictionary AELLTCD Lowest Level Term Code integer Adverse Event Dictionary (numeric codes) AEDECOD Dictionary-Derived Term text Adverse Event Dictionary AEPTCD Preferred Term Code integer Adverse Event Dictionary (numeric codes) AEHLT High Level Term text Adverse Event Dictionary AEHLTCD High Level Term Code integer Adverse Event Dictionary (numeric codes) AEHLGT High Level Group Term text Adverse Event Dictionary AEHLGTCD High Level Group Term Code integer Adverse Event Dictionary (numeric codes) AEBODSYS Body System or Organ Class text Adverse Event Dictionary AEBDSYCD Body System or Organ Class Code integer Adverse Event Dictionary (numeric codes) AESOC Primary System Organ Class text Adverse Event Dictionary AESOCCD Primary System Organ Class Code integer Adverse Event Dictionary (numeric codes)
7 External Dictionaries Reference Name External Dictionary Dictionary Version Adverse Event Dictionary (CL.AEDICT) MedDRA 12.0 Adverse Event Dictionary (numeric codes) (CL.AEDICT_N) MedDRA 12.0 Q: What should be specified if multiple different versions of the same dictionary were used, e.g. in integrated analyses? Create a unique reference name for every specific version of the external dictionary used in the datasets. A use case might be when data from multiple studies using different version of a coding dictionary are pooled for integrated analyses. The analyses will be done on the primary variables (e.g., AEDECOD, AEBODSYS) which are mapped to a common dictionary version. Variables like DECORG1, BDSYORG1 provide traceability to original (or prior) analyses. Variable Label Type Controlled Terms or Format AEDECOD Dictionary-Derived Term text Adverse Event Dictionary AEBODSYS Body System or Organ Class text Adverse Event Dictionary DECDORG1 PT in Original Dictionary 1 text Prior Adverse Event Dictionary BDSYORG1 SOC in Original Dictionary 1 text Prior Adverse Event Dictionary External Dictionaries Reference Name External Dictionary Dictionary Version Adverse Event Dictionary (CL.AEDICT) MedDRA 14.1 Prior Adverse Event Dictionary (CL.AEDICTP) MedDRA 12.0
It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0
PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges
More informationHands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania
PharmaSUG 2013 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis
More informationHands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania
PharmaSUG 2014 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data
More informationPharmaSUG Paper DS24
PharmaSUG 2017 - Paper DS24 ADQRS: Basic Principles for Building Questionnaire, Rating and Scale Datasets Nancy Brucken, inventiv Health, Ann Arbor, MI Karin LaPann, Shire, Lexington, MA ABSTRACT Questionnaires,
More informationAnalysis Data Model (ADaM) Data Structure for Adverse Event Analysis
Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis Prepared by the CDISC Analysis Data Model Team Notes to Readers This Analysis model uses the principles, structure and standards described
More informationBeyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC
Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity John Brega Linda Collins PharmaStat LLC Topics Part 1: A Standard with Many Uses Status of the Define.xml Standard
More informationThe Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA
PharmaSUG 2017 - Paper DS23 The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA ABSTRACT Since FDA released the Analysis
More informationStudy Data Reviewer s Guide Completion Guideline
Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on
More informationIntroduction to ADaM and What s new in ADaM
Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis
More informationApplying ADaM Principles in Developing a Response Analysis Dataset
PharmaSUG2010 Paper CD03 Applying ADaM Principles in Developing a Response Analysis Dataset Mei Dey, Merck & Co., Inc Lisa Pyle, Merck & Co., Inc ABSTRACT The Clinical Data Interchange Standards Consortium
More informationSDTM-ETL 3.1 User Manual and Tutorial
SDTM-ETL 3.1 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2014-07-19 Creating mappings for the AE domain Now that we have created (and executed) mappings for several domains, let
More informationDealing with changing versions of SDTM and Controlled Terminology (CT)
CDISC UK Network Breakout session Notes 07/06/16 Afternoon Session 1: Dealing with changing versions of SDTM and Controlled Terminology (CT) How do people manage this? Is this managed via a sponsor Standards
More informationRobust approach to create Define.xml v2.0. Vineet Jain
Robust approach to create Define.xml v2.0 Vineet Jain DEFINE SYSTEM GOALS Generic Powerful Reliable Integrable Efficient Works across SDTM, ADaM & SEND Create define.xml, annotated CRF & define.pdf Create
More informationImplementing CDISC Using SAS. Full book available for purchase here.
Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models
More informationIntroduction to ADaM standards
Introduction to ADaM standards Elke Sennewald, Director Biostatistics EU/AP, 06 March 2009 1 Outline ADaM Version 2.0 / 2.1 General Considerations ADaM draft Version 2.1 ADaMIG draft Version 1.0 ADaM Variables
More informationDCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on
DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on 2011-05-12 1 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical
More informationTraceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA
ABSTRACT PharmaSUG 2013 - Paper PO13 Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA Traceability is one of the fundamentals of the ADaM Standard. However, there is not
More informationAn Efficient Solution to Efficacy ADaM Design and Implementation
PharmaSUG 2017 - Paper AD05 An Efficient Solution to Efficacy ADaM Design and Implementation Chengxin Li, Pfizer Consumer Healthcare, Madison, NJ, USA Zhongwei Zhou, Pfizer Consumer Healthcare, Madison,
More informationDoctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development
PharmaSUG 2018 - Paper DS-15 Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development Aakar Shah, Pfizer Inc; Tracy Sherman, Ephicacy Consulting Group, Inc.
More informationPhUSE EU Connect 2018 SI05. Define ing the Future. Nicola Perry and Johan Schoeman
PhUSE EU Connect 2018 SI05 Define ing the Future Nicola Perry and Johan Schoeman Introduction Difference s in Define v2 Consistency and Quality Hints and Tips Conclusion 2 Difference s in Define v2 Difference
More informationADaM Reviewer s Guide Interpretation and Implementation
Paper CD13 ADaM Reviewer s Guide Interpretation and Implementation Steve Griffiths, GlaxoSmithKline, Stockley Park, UK ABSTRACT Throughout the course of a study, teams will make a lot of decisions about
More informationStandardizing FDA Data to Improve Success in Pediatric Drug Development
Paper RA01 Standardizing FDA Data to Improve Success in Pediatric Drug Development Case Study: Harmonizing Hypertensive Pediatric Data across Sponsors using SAS and the CDISC Model Julie Maddox, SAS Institute,
More informationSDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards
Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched
More informationPharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA
PharmaSUG 2013 - Paper DS06 Designing and Tuning ADaM Datasets Songhui ZHU, K&L Consulting Services, Fort Washington, PA ABSTRACT The developers/authors of CDISC ADaM Model and ADaM IG made enormous effort
More informationCreating an ADaM Data Set for Correlation Analyses
PharmaSUG 2018 - Paper DS-17 ABSTRACT Creating an ADaM Data Set for Correlation Analyses Chad Melson, Experis Clinical, Cincinnati, OH The purpose of a correlation analysis is to evaluate relationships
More informationCodelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California
ABSTRACT PharmaSUG 2016 - Paper DS16 lists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California Programming SDTM and ADaM data sets for a single
More informationADaM and traceability: Chiesi experience
ADaM and traceability: Chiesi experience BIAS Seminar «Data handling and reporting in clinical trials with SAS» Glauco Cappellini 22-Feb-2013 Agenda Chiesi Model for Biometrics Regulatory Background ADaM:
More informationSome Considerations When Designing ADaM Datasets
Some Considerations When Designing ADaM Datasets Italian CDISC UN Day - Milan 27 th October 2017 Antonio Valenti Principal Statistical Programmer CROS NT - Verona Content Disclaimer All content included
More informationADaM IG v1.1 & ADaM OCCDS v1.0. Dr. Silke Hochstaedter
ADaM IG v1.1 & ADaM OCCDS v1.0 Dr. Silke Hochstaedter 1 Agenda What s new in Analysis Data Model Implementation Guide Version 1.1 The new ADaM Structure for Occurrence Data (OCCDS) Version 1.0 Q&A ADaM
More informationDefine.xml 2.0: More Functional, More Challenging
Define.xml 2.0: More Functional, More Challenging Bay Area CDISC Implementation Network 24 July 2013 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the new features in Define.xml 2.0 with
More informationMaking a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets
PharmaSUG2011 Paper CD17 Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets Elizabeth Li, PharmaStat LLC, Newark, California Linda Collins, PharmaStat
More informationUpdates on CDISC Standards Validation
Updates on CDISC Standards Validation NJ CDISC User Group September 19, 2013 Topics CDISC standards validation initiative FDA update on SEND checks OpenCDISC v1.4.1 release OpenCDISC plans 2 CDISC validation
More informationHow to write ADaM specifications like a ninja.
Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation
More informationHarmonizing CDISC Data Standards across Companies: A Practical Overview with Examples
PharmaSUG 2017 - Paper DS06 Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples Keith Shusterman, Chiltern; Prathima Surabhi, AstraZeneca; Binoy Varghese, Medimmune ABSTRACT
More informationCDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting
CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.
More informationADaM Compliance Starts with ADaM Specifications
PharmaSUG 2017 - Paper DS16 ADaM Compliance Starts with ADaM Specifications Trevor Mankus, Kent Letourneau, PRA Health Sciences ABSTRACT As of December 17th, 2016, the FDA and PMDA require that all new
More informationHow to handle different versions of SDTM & DEFINE generation in a Single Study?
Paper CD15 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai,
More informationPharmaSUG DS05
PharmaSUG 2013 - DS05 Building Traceability for End Points in Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen Cui, Vertex Pharmaceuticals Incorporated Tathabbai Pakalapati, Cytel Inc. Qunming
More informationesubmission - Are you really Compliant?
ABSTRACT PharmaSUG 2018 - Paper SS21 esubmission - Are you really Compliant? Majdoub Haloui, Merck & Co., Inc., Upper Gwynedd, PA, USA Suhas R. Sanjee, Merck & Co., Inc., Upper Gwynedd, PA, USA Pinnacle
More informationEdwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India
Paper CD15 PhUSE 2016 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences,
More informationBest Practice for Explaining Validation Results in the Study Data Reviewer s Guide
Paper DS06 Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide Kristin Kelly, Pinnacle 21 LLC, Plymouth Meeting, PA, USA Michael Beers, Pinnacle 21 LLC, Plymouth Meeting,
More informationXiangchen (Bob) Cui, Alkermes Inc., Waltham, MA
PharmaSUG2015 - Paper AD06 A SAS Macro Tool to Automate Generation of Define.xml V2.0 from ADaM Specification for FDA Submission Min Chen, Alkermes Inc., Waltham, MA ABSTRACT Xiangchen (Bob) Cui, Alkermes
More informationMetadata and ADaM.
Metadata and ADaM 1 Disclaimer Any views or opinions presented in this presentation are solely those of the author and do not necessarily represent those of the company. 2 Agenda Introduction of ADaM Metadata
More informationFrom Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...
From Implementing CDISC Using SAS. Full book available for purchase here. Contents About This Book... xi About The Authors... xvii Acknowledgments... xix Chapter 1: Implementation Strategies... 1 Why CDISC
More informationTraceability: Some Thoughts and Examples for ADaM Needs
PharmaSUG 2018 - Paper DS-01 Traceability: Some Thoughts and Examples for ADaM Needs Sandra Minjoe, PRA Health Sciences; Wayne Zhong, Accretion Softworks; Quan (Jenny) Zhou, Eli Lilly and Company; Kent
More informationADaM Implementation Guide Status Update
ADaM Implementation Guide Status Update John K. Troxell John Troxell Consulting LLC Bridgewater, NJ jktroxell@gmail.com June 17, 2013 Current CDISC ADaM Documents 2009 Analysis Data Model (ADaM), Version
More informationPlanning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database
PharmaSUG 2017 - Paper DS13 Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database ABSTRACT Cori Kramer, Ragini Hari, Keith Shusterman, Chiltern When SDTM
More informationPharmaSUG Paper DS-24. Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP
PharmaSUG 2018 - Paper DS-24 Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP Kamlesh Patel, Rang Technologies Inc, New Jersey Jigar Patel, Rang Technologies Inc, New Jersey Dilip Patel,
More informationSDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6
SDTM-ETL TM New features in version 1.6 Author: Jozef Aerts XML4Pharma July 2011 p.1/14 Table of Contents Implementation of SEND v.3.0 final...3 Automated creation of the RELREC dataset and records...4
More informationPMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015
PMDA Valida+on Rules Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency Max Kanevsky December 10, 2015 Presenter Max Kanevsky Founder of OpenCDISC CEO of Pinnacle
More informationAvoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation
ABSTRACT Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation Richann Watson, Experis, Batavia, OH Karl Miller, inventiv Health, Lincoln, NE The ADaM Implementation Guide was created
More informationDIA 11234: CDER Data Standards Common Issues Document webinar questions
Q: What is the preferred data definition format for ADaM analysis data, define.xml or define.pdf? 1 ADaM Define File Q: The CRTDDS does not describe how to submit a define.xml for ADaM. Does CDER expect
More informationADaM for Medical Devices: Extending the Current ADaM Structures
PharmaSUG 2018 - Paper MD-02 ADaM for Medical s: Extending the Current ADaM Structures Sandra Minjoe, PRA Health Sciences; Julia Yang, Medtronic PLC; Priya Gopal, TESARO, Inc. ABSTRACT The current ADaM
More informationABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES
Developing Integrated Summary of Safety Database using CDISC Standards Rajkumar Sharma, Genentech Inc., A member of the Roche Group, South San Francisco, CA ABSTRACT Most individual trials are not powered
More informationADaM Implementation Guide Prepared by the CDISC ADaM Team
1 2 3 ADaM Implementation Guide Prepared by the CDISC ADaM Team 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Revision History Notes to Readers Date Version Summary of Changes May 30, 2008 1.0 Draft
More informationSubmission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA
PharmaSUG 2016 - Paper SS12 Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA ABSTRACT SAS Clinical Data Integration simplifies the
More informationWhat is high quality study metadata?
What is high quality study metadata? Sergiy Sirichenko PhUSE Annual Conference Barcelona, 2016 What is study metadata? Trial Design domains Reviewer s Guides acrf Define.xml Conclusion Topics What is study
More informationAdvanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD
Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM Ajay Gupta, PPD INTRODUCTION + TIBCO Spotfire is an analytics and business intelligence platform, which enables data visualization in
More informationGenerating Define.xml from Pinnacle 21 Community
PharmaSUG 2018 - Paper AD-29 ABSTRACT Generating Define.xml from Pinnacle 21 Community Pinky Anandani Dutta, Inclin, Inc Define.xml is an XML document that describes the structure and contents (metadata
More informationSDTM-ETL 3.2 User Manual and Tutorial
SDTM-ETL 3.2 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2017-07-29 Adding mappings for the Vital Signs domain After loading and validating the ODM file with metadata, your load
More informationAutomate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.
Automate Analysis Results Metadata in the Define-XML v2.0 Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc., USA 1 Topics Introduction Analysis Results Metadata (ARM) Version 1.0 o o
More informationOptimization of the traceability when applying an ADaM Parallel Conversion Method
SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method Roxane Debrus ADaM Conversion Process Agenda %LIB_QC_contents_html %adam_sdtm_compa Conclusion ADaM Conversion Process
More informationCDISC Standards End-to-End: Enabling QbD in Data Management Sam Hume
CDISC Standards End-to-End: Enabling QbD in Data Management Sam Hume 1 Shared Health and Research Electronic Library (SHARE) A global electronic repository for developing, integrating
More informationConversion of CDISC specifications to CDISC data specifications driven SAS programming for CDISC data mapping
PharmaSUG 2017 - Paper DA03 Conversion of CDISC specifications to CDISC data specifications driven SAS programming for CDISC data mapping Yurong Dai, Jiangang Jameson Cai, Eli Lilly and Company ABSTRACT
More informationCreating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS
Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS Agenda Introduction to the SAS Clinical Standards Toolkit (CST) Define-XML History and Background What is Define-XML?
More informationA Macro for Generating the Adverse Events Summary for ClinicalTrials.gov
SESUG Paper AD-127-2017 A Macro for Generating the Adverse Events Summary for ClinicalTrials.gov Andrew Moseby and Maya Barton, Rho, Inc. ABSTRACT In the clinical trials industry, the website ClinicalTrials.gov
More informationAnalysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team
Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team Notes to Readers This Implementation Guide is version 1.1 and corresponds to Version 2.1 of the
More informationTraceability Look for the source of your analysis results
Traceability Look for the source of your analysis results Herman Ament, Cromsource CDISC UG Milan 21 October 2016 Contents Introduction, history and CDISC Traceability Examples Conclusion 2 / 24 Introduction,
More informationOptimization of the traceability when applying an ADaM Parallel Conversion Method
Paper SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method DEBRUS Roxane, Business & Decision Life Sciences, Brussels, Belgium ABSTRACT One of the methods to create CDISC
More informationMaterial covered in the Dec 2014 FDA Binding Guidances
Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material
More informationWhat is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting
Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting
More informationLinking Metadata from CDASH to ADaM Author: João Gonçalves Business & Decision Life Sciences, Brussels, Belgium
PhUSE 2016 Paper CD10 Linking Metadata from CDASH to ADaM Author: João Gonçalves Business & Decision Life Sciences, Brussels, Belgium ABSTRACT CDISC standards include instructions describing how variables
More informationDeriving Rows in CDISC ADaM BDS Datasets
ABSTRACT PharmaSUG 2017 Paper DS22 Deriving Rows in CDISC ADaM BDS Datasets Sandra Minjoe, Accenture Accelerated R&D Services The ADaM Basic Data Structure (BDS) can be used for many analysis needs, including
More informationXiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA
Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA 2010 Vertex
More informationYes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes!
1 Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes! The ADaM documentation provides examples of many of
More informationWhy organizations need MDR system to manage clinical metadata?
PharmaSUG 2018 - Paper SS-17 Why organizations need MDR system to manage clinical metadata? Abhinav Jain, Ephicacy Consulting Group Inc. ABSTRACT In the last decade, CDISC standards undoubtedly have transformed
More informationThe Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008
The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits
More informationFacilitating Data Integration for Regulatory Submissions
SCSUG2010 Facilitating Data Integration for Regulatory Submissions John R. Gerlach, SAS / CDISC Analyst, Hamilton, NJ John C. Bowen (Retired), Merck & Co., Rahway, NJ ABSTRACT The process of integrating
More informationBusiness & Decision Life Sciences
Business & Decision Life Sciences Moving to Define.xml v2.0.0 for CDISC FSUG Anne-Sophie Bekx / 22 May 2014 Introduction Differences Impact Introduction History of Define.xml February 2005: CRT-DDS Final
More informationCreating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit
Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Lex Jansen Principal Software Developer @ SAS PharmaSUG 2016 Agenda Why Analysis Results Metadata?
More informationUse of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission
PharmaSUG 2017 - Paper SS03 Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission ABSTRACT Tianshu Li, Celldex Therapeutics, Hampton, NJ Traceability is one of the
More informationStudy Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata
Paper SD02 Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata Dr. Philippe Verplancke, XClinical GmbH, Munich, Germany ABSTRACT define.xml is often created at the end of
More informationConsiderations on creation of SDTM datasets for extended studies
13/May/2016 As one of the activities of CDISC Japan User Group (CJUG), a small group, "Extension study team" was organized in 2015. The team discussed what kind of approach works better for SDTM creation
More informationChallenges with the interpreta/on of CDISC - Who can we trust?
Challenges with the interpreta/on of CDISC - Who can we trust? Linda Palm Simonsson linda.simonsson@i- mind.se CD01 #PhUSE14 - London 2014-10- 13 Abstract Many smaller companies have none or very linle
More informationDataset-XML - A New CDISC Standard
Dataset-XML - A New CDISC Standard Lex Jansen Principal Software Developer @ SAS CDISC XML Technologies Team Single Day Event CDISC Tools and Optimization September 29, 2014, Cary, NC Agenda Dataset-XML
More informationSDTM Validation Rules in XQuery
SDTM Validation Rules in XQuery FH-Prof. Dr. Jozef Aerts Univ. Appl. Sciences FH Joanneum Graz, Austria Can you understand the following validation rule (part 1)? SDTM Validation Rules in XQuery Jozef
More informationPharmaceutical Applications
Automating File Creation: Metadata Files Speeding the Process Daphne Ewing, Auxilium Pharmaceuticals, Inc, Malvern, PA ABSTRACT For small to mid-size companies that cannot afford to purchase expensive
More informationDefine 2.0: What is new? How to switch from 1.0 to 2.0? Presented by FH-Prof.Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria
1 Define 2.0: What is new? How to switch from 1.0 to 2.0? Presented by FH-Prof.Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria 2 What's new in define.xml 2.0? Based on ODM 1.3(.2)
More informationHow Macro Design and Program Structure Impacts GPP (Good Programming Practice) in TLF Coding
How Macro Design and Program Structure Impacts GPP (Good Programming Practice) in TLF Coding Galyna Repetatska, Kyiv, Ukraine PhUSE 2016, Barcelona Agenda Number of operations for SAS processor: between
More informationCDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams
CDASH MODEL 1.0 AND CDASHIG 2.0 Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams 1 What is CDASH? Clinical Data Acquisition Standards Harmonization (CDASH) Standards for the collection
More informationThe Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method
PharmaSUG 2015 - Paper AD01 The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA ABSTRACT
More informationRiepilogo e Spazio Q&A
Riepilogo e Spazio Q&A CDISC Italian User Network Day 27 Ottobre 2017 Angelo Tinazzi (Cytel) - Silvia Faini (CROS NT) E3C members 2 Agenda ADaM key list Bad & Good ADaM...More... Spazio Q&A ADaM Key List
More informationSAS offers technology to facilitate working with CDISC standards : the metadata perspective.
SAS offers technology to facilitate working with CDISC standards : the metadata perspective. Mark Lambrecht, PhD Principal Consultant, Life Sciences SAS Agenda SAS actively supports CDISC standards Tools
More informationManaging CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences
1 Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences 2 Content Standards Technical Standards SDTM v1.1 SDTM IG v3.1.1
More informationPharmaSUG2014 Paper DS09
PharmaSUG2014 Paper DS09 An ADaM Interim Dataset for Time-to-Event Analysis Needs Tom Santopoli, Accenture, Berwyn, PA Kim Minkalis, Accenture, Berwyn, PA Sandra Minjoe, Accenture, Berwyn, PA ABSTRACT
More informationKnock Knock!!! Who s There??? Challenges faced while pooling data and studies for FDA submission Amit Baid, CLINPROBE LLC, Acworth, GA USA
PharmaSUG China 2018 Paper CD-03 Knock Knock!!! Who s There??? Challenges faced while pooling data and studies for FDA submission Amit Baid, CLINPROBE LLC, Acworth, GA USA ABSTRACT Pooling studies is not
More informationCreating Define-XML v2 with the SAS Clinical Standards Toolkit
SAS Super Demo Creating Define-XML v2 with the SAS Clinical Standards Toolkit Lex Jansen, SAS SAS Clinical Standards Toolkit 1.7 INTRODUCTION Framework to primarily support Clinical Research activities
More informationImplementing CDISC at Boehringer Ingelheim
Paper CD03 Implementing CDISC at Boehringer Ingelheim Michael Knoessl, Boehringer Ingelheim, Ingelheim, Germany Peter Leister, IBM, Hamburg, Germany ABSTRACT The Study Data Tabulation Model (SDTM), as
More informationProgramming checks: Reviewing the overall quality of the deliverables without parallel programming
PharmaSUG 2016 Paper IB04 Programming checks: Reviewing the overall quality of the deliverables without parallel programming Shailendra Phadke, Baxalta US Inc., Cambridge MA Veronika Csom, Baxalta US Inc.,
More informationFrom SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI
PharmaSUG2011 - Paper HW05 From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI ABSTRACT You've just read through the protocol,
More information